Chang-Feng Liu1, Xin-Ping Shi2, Yun Chen1, Ye Jin1, Bing Zhang1. 1. Department of General Surgery, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang Province, China. 2. Department of Clinical Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang Province, China.
Abstract
BACKGROUND: The survival rate of septic patients mainly depends on a rapid and reliable diagnosis. A rapid, broad range, specific and sensitive quantitative diagnostic test is the urgent need. Thus, we developed a TaqMan-Based Multiplex real-time PCR assays to identify bloodstream pathogens within a few hours. METHODS: Primers and TaqMan probes were designed to be complementary to conserved regions in the 16S rDNA gene of different kinds of bacteria. To evaluate accurately, sensitively, and specifically, the known bacteria samples (Standard strains, whole blood samples) are determined by TaqMan-Based Multiplex real-time PCR. In addition, 30 blood samples taken from patients with clinical symptoms of sepsis were tested by TaqMan-Based Multiplex real-time PCR and blood culture. RESULTS: The mean frequency of positive for Multiplex real-time PCR was 96% at a concentration of 100 CFU/mL, and it was 100% at a concentration greater than 1000 CFU/mL. All the known blood samples and Standard strains were detected positively by TaqMan-Based Multiplex PCR, no PCR products were detected when DNAs from other bacterium were used in the multiplex assay. Among the 30 patients with clinical symptoms of sepsis, 18 patients were confirmed positive by Multiplex real-time PCR and seven patients were confirmed positive by blood culture. CONCLUSION: TaqMan-Based Multiplex real-time PCR assay with highly sensitivity, specificity and broad detection range, is a rapid and accurate method in the detection of bacterial pathogens of sepsis and should have a promising usage in the diagnosis of sepsis.
BACKGROUND: The survival rate of septic patients mainly depends on a rapid and reliable diagnosis. A rapid, broad range, specific and sensitive quantitative diagnostic test is the urgent need. Thus, we developed a TaqMan-Based Multiplex real-time PCR assays to identify bloodstream pathogens within a few hours. METHODS: Primers and TaqMan probes were designed to be complementary to conserved regions in the 16S rDNA gene of different kinds of bacteria. To evaluate accurately, sensitively, and specifically, the known bacteria samples (Standard strains, whole blood samples) are determined by TaqMan-Based Multiplex real-time PCR. In addition, 30 blood samples taken from patients with clinical symptoms of sepsis were tested by TaqMan-Based Multiplex real-time PCR and blood culture. RESULTS: The mean frequency of positive for Multiplex real-time PCR was 96% at a concentration of 100 CFU/mL, and it was 100% at a concentration greater than 1000 CFU/mL. All the known blood samples and Standard strains were detected positively by TaqMan-Based Multiplex PCR, no PCR products were detected when DNAs from other bacterium were used in the multiplex assay. Among the 30 patients with clinical symptoms of sepsis, 18 patients were confirmed positive by Multiplex real-time PCR and seven patients were confirmed positive by blood culture. CONCLUSION: TaqMan-Based Multiplex real-time PCR assay with highly sensitivity, specificity and broad detection range, is a rapid and accurate method in the detection of bacterial pathogens of sepsis and should have a promising usage in the diagnosis of sepsis.
Authors: Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang Journal: Crit Care Med Date: 2006-06 Impact factor: 7.598
Authors: Niccolò Buetti; Jonas Marschall; Andrew Atkinson; Andreas Kronenberg Journal: Infect Control Hosp Epidemiol Date: 2016-06-28 Impact factor: 3.254
Authors: David J Ecker; Rangarajan Sampath; Haijing Li; Christian Massire; Heather E Matthews; Donna Toleno; Thomas A Hall; Lawrence B Blyn; Mark W Eshoo; Raymond Ranken; Steven A Hofstadler; Yi-Wei Tang Journal: Expert Rev Mol Diagn Date: 2010-05 Impact factor: 5.225
Authors: J Wilson; S Elgohari; D M Livermore; B Cookson; A Johnson; T Lamagni; A Chronias; E Sheridan Journal: Clin Microbiol Infect Date: 2011-03 Impact factor: 8.067
Authors: Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond Journal: Clin Infect Dis Date: 2004-07-15 Impact factor: 9.079
Authors: Davidson H Hamer; Gary L Darmstadt; John B Carlin; Anita K M Zaidi; Kojo Yeboah-Antwi; Samir K Saha; Pallab Ray; Anil Narang; Eduardo Mazzi; Praveen Kumar; Arti Kapil; Prakash M Jeena; Ashok Deorari; A K Azad Chowdury; Andrés Bartos; Zulfiqar A Bhutta; Yaw Adu-Sarkodie; Miriam Adhikari; Emmanuel Addo-Yobo; Martin W Weber Journal: Pediatr Infect Dis J Date: 2015-01 Impact factor: 2.129